Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Henze

Showing results (201-210 of 231) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|May 1, 2001
Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemiaJ P Vieira Pinheiro, H J Müller, D Schwabe, et al.
Klinische Padiatrie|July 1, 1982
[Cooperative osteosarcoma study COSS-77: results after 4 years]K Winkler, G Beron, G Schellong, et al.
Leukemia|March 12, 2004
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGFS Wellmann, M Guschmann, W Griethe, et al.
Klinische Padiatrie|May 1, 1983
[Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years]U Creutzig, J Ritter, H J Langermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93U Creutzig, J Ritter, M Zimmermann, et al.
Leukemia|May 7, 2011
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatmentC Eckert, T Flohr, R Koehler, et al.
Klinische Padiatrie|September 23, 1998
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trialsM Schrappe, A Reiter, G Henze, et al.
Blood|April 16, 1998
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemiaM L den Boer, R Pieters, K M Kazemier, et al.
British Journal of Haematology|September 6, 2000
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocolsH J Müller, L Löning, A Horn, et al.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Pageof 24

Showing results (201-210 of 231) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|May 1, 2001
Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemiaJ P Vieira Pinheiro, H J Müller, D Schwabe, et al.
Klinische Padiatrie|July 1, 1982
[Cooperative osteosarcoma study COSS-77: results after 4 years]K Winkler, G Beron, G Schellong, et al.
Leukemia|March 12, 2004
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGFS Wellmann, M Guschmann, W Griethe, et al.
Klinische Padiatrie|May 1, 1983
[Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years]U Creutzig, J Ritter, H J Langermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93U Creutzig, J Ritter, M Zimmermann, et al.
Leukemia|May 7, 2011
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatmentC Eckert, T Flohr, R Koehler, et al.
Klinische Padiatrie|September 23, 1998
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trialsM Schrappe, A Reiter, G Henze, et al.
Blood|April 16, 1998
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemiaM L den Boer, R Pieters, K M Kazemier, et al.
British Journal of Haematology|September 6, 2000
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocolsH J Müller, L Löning, A Horn, et al.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Pageof 24